Nuveen Asset Management, LLC Werewolf Therapeutics, Inc. Transaction History
Nuveen Asset Management, LLC
- $345 Billion
- Q3 2024
A detailed history of Nuveen Asset Management, LLC transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 73,370 shares of HOWL stock, worth $116,658. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,370
Previous 52,048
40.97%
Holding current value
$116,658
Previous $126,000
23.02%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding HOWL
# of Institutions
69Shares Held
31.8MCall Options Held
700Put Options Held
500-
Ra Capital Management, L.P. Boston, MA6.14MShares$9.77 Million0.18% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.28MShares$6.81 Million6.25% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.4MShares$5.4 Million0.42% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.39MShares$3.8 Million0.79% of portfolio
-
Bank Of America Corp Charlotte, NC2.15MShares$3.42 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $47M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...